Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area metabolism cyp3a cyp450'

Search results for: 'research area metabolism cyp3a cyp450'

Items 51-60 of 238

Page
per page
  1. LCQ-908
    A3542 LCQ-908
    Summary: DGAT1 inhibitor
      Soluble in DMSO
  2. Abiraterone acetate
    A8202 Abiraterone acetate
    Target: Cytochrome P450 (CYP450)
    Summary: Cytochrome p450 17a1 inhibitor
      insoluble in H2O; ≥11.22 mg/mL
  3. Abiraterone
    A4240 Abiraterone
     1 Citation
    Summary: Potent CYP17 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥5.57 mg/mL
  4. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer
      ≥23.7 mg/mL
  5. GSK3787
    A4303 GSK3787
    Summary: PPARβ/δ antagonist,novel and irreversible
      insoluble in H2O; ≥15.8 mg/mL
  6. Rosiglitazone
    A4304 Rosiglitazone
    Summary: Potent PPARγ agonist
      insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
  7. GW0742
    A4307 GW0742
    Summary: PPARδ/β agonist,potent and selective
      ≥47.1 mg/mL
  8. PF-4981517
    A4311 PF-4981517
    Summary: CYP3A4 inhibitor,potent and selective
      Soluble in DMSO
  9. Ketoconazole
    A4316 Ketoconazole
    Target: Cytochrome P450 (CYP450)
    Summary: Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase
      ≥23.4 mg/mL
  10. Apremilast (CC-10004)
    A4317 Apremilast (CC-10004)
    Target: Phosphodiesterases (PDEs)
    Summary: PDE4 inhibitor
      ≥23.05 mg/mL

Items 51-60 of 238

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 126item
  2. Natural Products 4item
  3. Protein 12item
  4. Kits 12item
  5. Screening Library 31item
  6. Peptides 1 item
  7. Probes & Dyes 1 item
  8. Cell Biology 9item
  9. Peptides & Proteins 46item
  10. Protein & Immunology 1 item
Specificity
  1. Selective 47item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 4item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 10item
  4. RARs 1 item
  5. Trk Receptors 1 item
  6. Estrogen and Related Receptors 1 item
  7. EGFR 1 item
  8. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  9. AMPK 1 item
  10. Cytochrome P450 (CYP450) 4item
  11. Ferroptosis 1 item
  12. HMG-CoA Reductases 3item
  13. SGLT 1 item
  14. DGAT 2item
  15. Insulin and Insulin-like Receptors 1 item
  16. Pyruvate dehydrogenases (PDH) 1 item
  17. CETP 2item
  18. Fatty-acid-binding proteins (FABPs) 1 item
  19. Folate Analogue 1 item
  20. IDH2 1 item
  21. Nampt 1 item
  22. Carbonic Anhydrases 3item
  23. Histamine H1 Receptors 1 item
  24. Phospholipases 1 item
  25. Catechol O-Methyltransferase (COMT) 1 item
  26. Hydroxylases 1 item
  27. ATGL 1 item
  28. FPTase 1 item
  29. PPAR 1 item
  30. FAAH 1 item
  31. carnitine reabsorption 1 item
  32. TRPC channel 1 item
Reported Experiments
  1. Animal Experiments 59item
  2. Cell Experiments 53item
Related Disease
  1. Acne 1 item
  2. Acute Kidney Injury 1 item
  3. Acute Myelogenous Leukemia 1 item
  4. Bladder Cancer 1 item
  5. Bladder Carcinoma 1 item
  6. Brain Injuries Studies 1 item
  7. Breast Cancer 5item
  8. Cancer 15item
  9. Cervical Cancer 1 item
  10. Cocaine-Related Disorders 1 item
  11. Diabetes 1 item
  12. Dyslipidemia 2item
  13. Erectile Dysfunction 3item
  14. HIV 1 item
  15. Hypercholesterolemia 2item
  16. Inflammation 1 item
  17. Inflammatory Diseases 2item
  18. Kidney Injury Studies 1 item
  19. Leukemia 2item
  20. Lung Cancer 2item
  21. Lymphoma 3item
  22. Melanoma 2item
  23. Neuroblastoma 3item
  24. Neurocognitive Disorders 1 item
  25. Obsessive-Compulsive Disorder 1 item
  26. Prostate Cancer 2item
  27. Psoriasis 2item
  28. Psoriasis Vulgaris 1 item
  29. Pulmonary Arterial Hypertension 1 item
  30. Rheumatoid Arthritis 2item
  31. Schizophrenia 2item
  32. Type 2 Diabetes 4item